Workflow
General Healthy(605186)
icon
Search documents
健麾信息(605186) - 上海健麾信息技术股份有限公司关于更换持续督导保荐代表人的公告
2025-11-14 09:15
证券代码:605186 证券简称: 健麾信息 公告编号:2025-041 上海健麾信息技术股份有限公司 关于更换持续督导保荐代表人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 上海健麾信息技术股份有限公司(以下简称"公司")于近日收到国信证券 股份有限公司(以下简称"国信证券")出具的《关于指定上海健麾信息技术股 份有限公司首次公开发行股票持续督导保荐代表人的函》。 附件:刘雅昕先生简历 国信证券作为公司首次公开发行股票并上市的保荐机构,原委托孙婕女士和 陈振瑜先生担任公司持续督导工作的保荐代表人,现因陈振瑜先生个人工作变动, 不能继续履行对公司的持续督导职责。为保证持续督导工作的有序进行,国信证 券委派刘雅昕先生(简历详见附件)接替陈振瑜先生担任公司的保荐代表人,履 行对公司的持续督导职责。 刘雅昕先生,国信证券投资银行事业部上海业务总部高级业务总监,临床医 学硕士,保荐代表人。2015 年开始从事投资银行业务,曾参与开拓药业股转中 心挂牌项目、晶瑞股份可转债项目、天士力医药集团股份有限公司重大资产出售 项目、南山 ...
【盘中播报】39只股长线走稳 站上年线
Core Points - The Shanghai Composite Index is at 4008.92 points, above the annual line, with a change of 0.22% [1] - A total trading volume of A-shares reached 894.89 billion yuan today [1] - 39 A-shares have surpassed the annual line, with notable stocks including Hangxin Technology, Liwang Co., and Chuanfa Longmang, showing significant deviation rates [1] Summary by Category Market Performance - The Shanghai Composite Index is currently at 4008.92 points, reflecting a 0.22% increase [1] - The total trading volume for A-shares today is 894.89 billion yuan [1] Stocks Surpassing Annual Line - 39 A-shares have crossed the annual line, with the highest deviation rates recorded for: - Hangxin Technology: 4.59% - Liwang Co.: 3.56% - Chuanfa Longmang: 3.27% [1] - Other stocks with smaller deviation rates include: - Jiuzhou Group - Dali Kaipu - Tiens Wind Power [1] Detailed Stock Data - Notable stocks and their performance: - Hangxin Technology: +4.52%, turnover rate 5.95%, latest price 17.34 yuan, deviation rate 4.59% [1] - Liwang Co.: +5.42%, turnover rate 5.46%, latest price 28.02 yuan, deviation rate 3.56% [1] - Chuanfa Longmang: +3.57%, turnover rate 3.12%, latest price 13.07 yuan, deviation rate 3.27% [1]
大消费反攻!布局时点到了?丨每日研选
Sou Hu Cai Jing· 2025-11-11 01:05
Core Viewpoint - The consumer sector is showing signs of recovery, driven by favorable policies, rising CPI, and the imminent closure of Hainan Free Trade Port, leading to increased investment enthusiasm in the sector [2][4]. Group 1: Consumer Sector Analysis - The consumer sector is believed to be at the bottom, with fundamentals gradually improving, as indicated by the third-quarter reports [4]. - The "14th Five-Year Plan" emphasizes the importance of consumption, suggesting a positive outlook for the sector [4]. - Key investment opportunities include the restaurant chain sector, which is nearing the end of price wars, and companies like Anjiexin Foods and Lihai Foods are seeing improved net profit margins [4]. Group 2: Duty-Free Industry Insights - Hainan's duty-free sales data shows a significant recovery in Q3 2025, with a notable increase in average transaction value, and a stable outlook for Q4 [5]. - Continuous policy support, including a clear timeline for the island's closure and an expanded range of duty-free products, is expected to enhance the operational conditions for companies like China Duty Free Group and Hainan Development [5]. Group 3: Structural Upgrades in Consumption - The toy industry is evolving with IP incubation and category innovation, favoring leading companies with strong design and supply chain capabilities [6]. - The beauty industry is integrating medical, beauty, and health services, which is expected to enhance customer spending and repeat purchases [6]. - The consumer industry is transitioning from "functional supply" to "scenario value supply," indicating a structural upgrade in brand consumer goods [6]. Group 4: New Consumption Trends - Four new consumption themes are emerging: 1. Brand globalization 2.0, focusing on pricing power and emerging markets [7]. 2. Emotional value sectors like trendy toys and pet products are expected to benefit from rising GDP per capita [7]. 3. AI-driven consumption in service sectors is showing potential for profitability [7]. 4. Channel transformation emphasizing user experience and operational efficiency, particularly in instant retail and cost-effective dining [7]. Group 5: High-Growth Opportunities in Emotional Consumption - The gold and jewelry sector is undergoing significant changes, with rising gold prices and a shift towards emotional consumption, suggesting opportunities in high-end and trendy gold segments [8]. - Retail e-commerce is focusing on offline retail transformation and AI-enabled cross-border e-commerce leaders [8]. - The cosmetics sector is seeing growth in domestic brands that meet emotional value and safety ingredient innovation [8]. - The medical beauty sector remains resilient, with opportunities in differentiated products and mergers in downstream medical beauty institutions [8].
上海健麾信息技术股份有限公司第三届董事会第十一次会议决议公告
Group 1 - The board of directors of Shanghai Jianhui Information Technology Co., Ltd. held its 11th meeting of the third session on November 7, 2025, with all 8 directors present, and the meeting was conducted in accordance with relevant laws and regulations [2][4]. - The board approved a proposal to apply for a comprehensive credit facility from a bank, not exceeding RMB 750 million, to meet daily funding needs and improve capital operation capabilities [2][3]. - The proposal will be submitted to the shareholders' meeting for approval [5]. Group 2 - The first temporary shareholders' meeting of 2025 is scheduled for November 21, 2025, with a proposal to increase the agenda to include the comprehensive credit facility application [7][8]. - The proposal for the credit facility was submitted by Mr. Dai Jianwei, a shareholder holding 42% of the shares, and was formally presented to the meeting [8][9]. - The network voting system will be available on the day of the shareholders' meeting, allowing shareholders to vote during specified time slots [9].
健麾信息(605186) - 上海健麾信息技术股份有限公司关于2025年第一次临时股东大会增加临时提案暨补充通知的公告
2025-11-07 08:00
证券代码:605186 证券简称:健麾信息 公告编号:2025-040 上海健麾信息技术股份有限公司 关于2025年第一次临时股东大会增加临时提案暨补充通知 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、 股东大会有关情况 1. 股东大会的类型和届次: 2025年第一次临时股东大会 2. 股东大会召开日期:2025 年 11 月 21 日 3. 股权登记日 | 股份类别 | 股票代码 | 股票简称 | 股权登记日 | | --- | --- | --- | --- | | A股 | 605186 | 健麾信息 | 2025/11/14 | 公司已于2025 年 10 月 30 日公告了股东大会召开通知,单独或者合计持有 42.00%股份的股东戴建伟先生,在2025 年 11 月 7 日提出临时提案并书面提交股 东大会召集人。股东大会召集人按照《上市公司股东会规则》有关规定,现予以 公告。 3. 临时提案的具体内容 2025 年 11 月 7 日,公司收到单独或者合计持有 42.00%股份的股东戴建伟先 生提交的《 ...
健麾信息(605186) - 2025年第一次临时股东大会会议资料
2025-11-07 08:00
上海健麾信息技术股份有限公司 2025年第一次临时股东大会会议资料 证券代码:605186 证券简称:健麾信息 上海健麾信息技术股份有限公司 Shanghai General Healthy Information and Technology Co., Ltd. 2025 年第一次临时股东大会 会议资料 中国•上海 二〇二五年十一月二十一日 上海健麾信息技术股份有限公司 2025年第一次临时股东大会会议资料 目录 | | 2025 年第一次临时股东大会会议须知 1 | | --- | --- | | | 2025 年第一次临时股东大会会议议程 3 | | 议案一 | 关于取消监事会暨修订《公司章程》的议案 5 | | 议案二 | 关于修订《上海健麾信息技术股份有限公司股东大会议事规则》的议案 6 | | 议案三 | 关于修订《上海健麾信息技术股份有限公司董事会议事规则》的议案 7 | | 议案四 | 关于修订《上海健麾信息技术股份有限公司独立董事工作制度》的议案 8 | | 议案五 | 关于修订《上海健麾信息技术股份有限公司独立董事津贴管理办法》的议案 9 | | 议案六 | 关于修订《上海健麾信息技术股份 ...
健麾信息(605186) - 第三届董事会第十一次会议决议公告
2025-11-07 08:00
二、董事会会议审议情况 证券代码:605186 证券简称: 健麾信息 公告编号:2025-039 上海健麾信息技术股份有限公司 第三届董事会第十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 上海健麾信息技术股份有限公司(以下简称"公司")第三届董事会第十一 次会议于 2025 年 11 月 7 日上午以现场结合通讯方式召开,会议通知及相关材料 已于 2025 年 11 月 5 日通过电话及电子邮件等形式送达各位董事,全体董事同意 豁免本次会议通知时限。本次会议应出席董事 8 人,实际出席董事 8 人,全体董 事均亲自出席了本次会议。本次会议由公司董事长戴建伟先生主持,公司全体监 事和高级管理人员列席。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律法 规和《公司章程》等有关规定。 2025 年 11 月 8 日 经与会董事认真审议,会议形成了以下决议: 1、审议通过《关于向银行申请综合授信额度的议案》 根据公司及子公司经营发展计划,为满足日常资金需求,降低融资成本, ...
健麾信息(605186) - 立信会计师事务所(特殊普通合伙)关于上海健麾信息技术股份有限公司2025年半年度报告的信息披露监管问询函的回复
2025-11-06 08:01
1. 如无特殊说明,本回复中的术语、名称、简称与《上海健麾信息技术股份有 限公司 2025年半年度报告》中的术语、名称、简称具有相同含义; 2. 立信没有接受委托审计或审阅公司 2025年 1 月至 6 月期间的财务报表,因 此无法对公司上述期间的财务信息发表意见或结论; 3. 本回复说明中若出现总数与各分项数值之和尾数不符的情况,均系四舍五入 原因造成。 会计师事务所(特殊普通 IINA SHU LUN PAN CERTIFIED PUBLIC ACCOL 立信会计师事务所(特殊普通合伙) 关于上海健摩信息技术股份有限公司 2025 年半年度报告的信息披露监管问询函的回复 信会师函字[2025]第 ZA523 号 上海证券交易所上市公司管理一部: 根据贵部下发的《关于上海健摩信息技术股份有限公司 2025 年半年度报告 的信息披露监管问询函(上证公函《2025】1393 号)》("问询函")的要求,立 信会计师事务所(特殊普通合伙)("立信"、"年审会计师"或"我们")作 为上海健麾信息技术股份有限公司("健麾信息"或"公司")2023 年度、2024 年 度财务报表的审计机构,对问询函中与年审会计师有关事 ...
营业成本增速高于营业收入增速遭问询 健麾信息回复
Group 1 - The core issue highlighted is that the company's total operating costs have been growing at a rate significantly higher than its operating revenue, attracting the attention of the stock exchange [1][2] - In 2024, the company's operating revenue increased by 3.51% to 318 million yuan, while total operating costs surged by 33.48% to 292 million yuan [1] - For the first half of 2025, operating revenue rose by 9.03% to 159 million yuan, but total operating costs also increased by 33.18% to 140 million yuan [1] Group 2 - The decline in revenue from the traditional core business, the smart pharmacy project, was a significant factor, with a 56.84% drop to 86.39 million yuan and a corresponding decrease in gross margin by 12.83 percentage points [1] - New emerging businesses, such as the intelligent centralized dispensing center, experienced explosive growth with a revenue increase of 675.85% to 119 million yuan, but the high costs reduced overall profitability, with a gross margin of only 29.55%, down 16.86 percentage points from the previous year [1] - In the first half of 2025, the cost pressures from emerging businesses became more pronounced, with the intelligent centralized dispensing center's revenue increasing by 159.77%, but the newly added digital operating room module project had a gross margin of only around 20%, approximately 40 percentage points lower than the existing intravenous medication preparation system [2]
健麾信息(605186) - 国信证券股份有限公司关于上海健麾信息技术股份有限公司2025年半年度报告信息披露监管问询函回复的核查意见
2025-11-05 10:31
国信证券股份有限公司 关于上海健麾信息技术股份有限公司 2025 年半年度报告信息披露监管问询函回复的核查意见 上海健麾信息技术股份有限公司(以下简称"健麾信息"或"公司")于 2025 年 9 月 25 日收到上海证券交易所上市公司管理一部下发的《关于上海健麾信息 技术股份有限公司 2025 年半年度报告的信息披露监管问询函》(上证公函 【2025】1393 号)(以下简称"《问询函》")。国信证券股份有限公司(以下简 称"国信证券"或"保荐机构")作为健麾信息 IPO 的保荐机构,现对《问询函》 提及的相关问题出具核查意见如下: 【相关问题】 半年报显示,公司在建工程期末余额 1.03 亿元,同比增长 124.39%,均系 自有资金投入项目,其中钟祥医药数字化项目余额 8810.61 万元,工程进度为 48.02%;智慧药房配套项目余额 1482.13 万元,工程进度为 99.23%。此外,公 司首次公开发行股票募投项目药房自动化升级研发项目和自动化设备投放项目 原定完成时间为 2024 年 4 月,先后两次延期至 2025 年 3 月、2026 年 2 月。截 至报告期末,上述募投项目的投入进度分别为 ...